NCT03741738View on ClinicalTrials.gov

The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

June 9, 2020

Study Completion Date

June 9, 2020

Conditions
Vitiligo
Trial Locations (1)

03722

Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03741738 - The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity | Biotech Hunter | Biotech Hunter